Federated learning platform enabling GDPR-compliant genomic analysis collaboration between hospitals without raw data sharing. Targets NHS networks and precision medicine startups.
GenomeLink addresses healthcare’s data sovereignty challenge through a privacy-first federated learning platform. Designed for NHS networks and EU medical institutions, this solution enables collaborative AI model training on sensitive genomic datasets while maintaining strict GDPR compliance – potentially unlocking £320M in UK genomic medicine opportunities by 2026.
Core Functionality
Secure platform combining encrypted model training with multi-institutional collaboration tools. Features include:
- Privacy-preserving AI development environment
- Real-time compliance dashboards
- Automated HL7 FHIR EHR integration
- Blockchain-based audit trails
Target User and Segment
Primary clients:
- NHS Foundation Trust hospitals
- EU private healthcare networks
- Biomedical research consortia
- Precision medicine startups requiring GDPR solutions
Recommended Tech Stack
- Backend: Python/TensorFlow Federated
- Frontend: React.js analytics dashboard
- Security: AWS Nitro Enclaves + Hyperledger Fabric
- Compliance: OpenMined PySyft framework
Estimated MVP Costs
700-800 development hours at €100/hr:
- Federated core: 300h
- Security layer: 200h
- EHR integration: 150h
- Total: €70,000-€80,000
SWOT Analysis
- Strengths: NHS-first compliance automation
- Weaknesses: Requires rare ML+blockchain talent
- Opportunities: £320M UK genomic market by 2026
- Threats: OpenFL open-source alternatives
First 1000 Customers Strategy
€48k marketing budget targeting:
- NHS Digital accelerator partnerships
- MedTech Summit sponsorships
- LinkedIn ABM campaigns (15,000 leads)
- 3 NHS Trust pilots
Monetization
Tiered SaaS model:
- £8,000/mo base (500 samples)
- £15/additional sample
- Break-even: 42 hospital contracts
- Team: 8 FTEs (2 FL engineers, 1 compliance)
Market Positioning
- Focus: UK (60%), DACH (25%)
- Competitors: Owkin (€184M raised)
- Edge: NHS-specific compliance automation
- TAM Expansion: £850M with pharma partners
